Share on StockTwits

CareFusion (NYSE:CFN) CFO James F. Hinrichs unloaded 21,506 shares of the company’s stock in a transaction that occurred on Friday, June 6th. The shares were sold at an average price of $44.07, for a total transaction of $947,769.42. Following the sale, the chief financial officer now directly owns 27,024 shares of the company’s stock, valued at approximately $1,190,948. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

A number of research firms have recently commented on CFN. Analysts at Raymond James raised their price target on shares of CareFusion from $48.00 to $50.00 in a research note on Monday, May 19th. They now have a “strong-buy” rating on the stock. Separately, analysts at Zacks reiterated a “neutral” rating on shares of CareFusion in a research note on Wednesday, May 7th. They now have a $41.00 price target on the stock. Finally, analysts at Barclays cut their price target on shares of CareFusion from $44.00 to $42.00 in a research note on Tuesday, May 6th. They now have an “equal weight” rating on the stock. Four equities research analysts have rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company. CareFusion currently has a consensus rating of “Buy” and an average target price of $42.30.

Shares of CareFusion (NYSE:CFN) traded up 0.11% on Friday, hitting $43.77. The stock had a trading volume of 1,275,215 shares. CareFusion has a one year low of $35.01 and a one year high of $44.17. The stock has a 50-day moving average of $41.06 and a 200-day moving average of $40.29. The company has a market cap of $9.074 billion and a price-to-earnings ratio of 24.45.

CareFusion (NYSE:CFN) last posted its quarterly earnings results on Monday, May 5th. The company reported $0.60 EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.62 by $0.02. The company had revenue of $968.00 million for the quarter, compared to the consensus estimate of $986.67 million. During the same quarter in the prior year, the company posted $0.59 earnings per share. The company’s quarterly revenue was up 7.4% on a year-over-year basis. Analysts expect that CareFusion will post $2.31 EPS for the current fiscal year.

CareFusion Corporation (NYSE:CFN) is a global medical technology company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.